ArticleJournal of medicinal chemistry2024

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.

Christophe Peixoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.